The expression and significance of the angiopoietin-1 in the kidney of diabetic rats

Journal of Sichuan University (Medical Science)

Volumn 38, Issue 1, 2007, Pages

  Yang, Yi Bin ^a   Chen, Ze Jun ^a   Liu, Fei ^a   Huang, Song Min ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Angiogenesis; Angiopoietin 1; Diabetic nephropathy

Indexed keywords

ANGIOPOIETIN 1;

ANIMAL MODEL; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DIABETES MELLITUS; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; KIDNEY INJURY; KIDNEY PARENCHYMA; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 33846616488     PISSN: 1672173X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Flyvbjerg A. Putative pathophysiological role of growth factors and cytokines in experimental diabetic kidney disease. Diabetologia, 2000;43(10):1205-1223.
2. Satchell SC, Mathieson PW. Angiopoietins: microvascular modulators with potential roles in glomerular pathophysiology. J Nephrol, 2003;16(2):168-178.
3. Chinese source
4. Abdulmalek K, Ashur F, Ezer N, et al. Differential expression of Tie-2 receptors and angiopoietins in response to in vivo hypoxia in rats. Am J Physiol Lung Cell Mol Physiol, 2001;281 (3):L582-L590.
5. Yamamoto Y, Maeshima Y, Kitayama H, et al. Tumstatin peptide, an inhibitor of angiogenesis, prevents glomerular hypertrophy in the early stage of diabetic nephropathy. Diabetes, 2004;53(7):1831-1840.
6. Satchell SC, Anderson KL, Mathieson PW, et al. Angiopoietin 1 and vascular endothelial growth factor modulate human glomerular endothelial cell barrier properties. J Am Soc Nephrol, 2004;15(3):566-574.
7. Khamaisi M, Schrijvers B, de Vriese AS, et al. The emerging role of VEGF in diabetic kidney disease. Nephrol Dial Transplant, 2003;18(8):1427-1430.
8. Yuan HT, Tipping PG, Li XZ, et al. Angiopoietin correlates with glomerular capillary loss in anti-glomerular basement membrane glomerulonephritis. Kidney Int, 2002;61(6):2078-2089.
9. Long DA, Woolf AS, Suda T, et al. Increased renal angiopoietin-1 expression in folic acid-induced nephrotoxicity in mice. J Am Soc Nephrol, 2001;12(12):2721-2731.
10. Nyengaard JR, Rasch R. The impact of experimental diabetes mellitus in rats on glomerular capillary number and sizes. Diabetologia, 1993;36(3):189-194.
11. ØSterby R, Asplund J, Bangstad HJ, et al. Neovascularization at the vascular pole region in diabetic glomerulopathy. Nephrol Dial Transplant, 1999;14(2):348-352.
12. Enholm B, Paavonen K, Ristimaki A, et al. Comparison of VEGF, VEGF-B, VEGF-C and angiopoietin-1 mRNA regulation by serum growth factors, onooproteins and hypoxia. Oncogene, 1997;14(20):2475-2483.
13. Io H, Hamada C, Ro Y, et al. Morphologic change of peritoneum and expression of VEGF in encapsulated peritoneal sclerosis rat models. Kidney Int, 2004;65(5):1927-1936.
14. Joussen AM, Poulaki V, Tsujikawa A, et al. Suppression of diabetic retinopathy with angiopoietin-1. Am J Pathol, 2002; 160(5):1683-1693.